Abbott MediaRoom (Product) Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan - First minimally invasive device to treat people in Japan with common leaky heart valve for whom surgery is too risky Mon, 06 Nov 2017 08:00:00 -0500 Analysis Shows Better Health Outcomes and Cost Effectiveness for Coronary Intervention Using Abbott's Fractional Flow Reserve (FFR) Diagnostic in Patients with Stable Coronary Artery Disease - After three years, patients who underwent FFR-guided percutaneous coronary intervention (PCI) in combination with medical therapy had significantly fewer major adverse cardiac events compared to patients who received medical therapy alone Thu, 02 Nov 2017 12:10:00 -0400 Abbott Announces FDA Clearance for its Alinity™ ci-series Next-generation Diagnostic Systems - Innovative, harmonized solutions for chemical chemistry and immunoassay testing will help laboratories and hospital systems achieve measurably better healthcare performance Tue, 31 Oct 2017 09:00:00 -0400 Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery - Long-term health and quality of life were similar at three years for patients receiving a XIENCE stent and patients who underwent surgery Mon, 30 Oct 2017 13:20:00 -0400 Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1] - XIENCE Sierra™, the newest generation of drug-eluting XIENCE stent receives CE Mark, representing European approval Mon, 30 Oct 2017 07:00:00 -0400